[Event Report] The 2nd AMR Global Expert Meeting “Post G7 Ise-Shima Summit: Reflecting upon Japan’s National Action Plan and Addressing Next Steps for Global Antimicrobial Resistance” (July 21, 2017)
date : 7/21/2017
Tags: AMR
Kuniaki Miyake (Director, Tuberculosis and Infectious Diseases Control
Kazuhiro Tateda (President, The Japanese Association for Infectious Diseases/
Professor, Department of Microbiology and Infectious Diseases, Toho University)
Professor Tateda gave a keynote address on the future direction of infectious diseases treatments in the AMR Era. He emphasized the goal of promoting the appropriate use of antimicrobials, rather than just aiming to meet numerical targets and figures. He also pointed out the importance of education and efforts to spread knowledge among primary care physicians in order to enable them to practice the appropriate use of antimicrobials.
Panel Discussion 1
“G7 Ise-Shima Summit’s Achievements and Further Role to Combat AMR”
The discussion in Session 1 reflected on the changes made during the past year following the G7 Ise-Shima summit both globally and locally. The Panel elaborated on the complicated issue of the new framework for public-private partnerships (PPP) needed for AMR R&D policies.
• Gary M. Cohen (Executive Vice President and President, Global Health and Development, Becton, Dickinson and Company)
• Jayasree K. Iyer (Executive Director, Access to Medicine Foundation)
• Paul Schaper (Executive Director, Global Public Policy, Merck & Co., Inc., Kenilworth, N.J., U.S.A.)
• Naoko Yamamoto (Senior Assistant Minister for Global Health, MHLW)
Mayuka Yamazaki (Project Assistant Professor, Global Health Policy, Faculty of Medicine, The University of Tokyo)
Panel Discussion 2
“Challenges and Next Agendas in Japan’s National Action Plan”
In this session, experts had a focused discussion on the remaining challenges and future agenda related to Japan’s National Action Plan, including incentives to foster antimicrobial development as well as possible frameworks for the government-industry-academia partnerships critical to that process.
• Norio Ohmagari (Vice Director, National Center for Global Health and Medicine / Director, Disease Control and Prevention Center(DCC) / Director, International Health Care Center at DCC)
• Takuko Sawada (Director of the Board, Senior Executive Officer, Senior Vice President, Corporate Strategy Division, Shionogi & Co., Ltd.)
• Kazuhiko Mori (Director, Evaluation and Licensing Division, MHLW)
• Katsunori Yanagihara (Professor, Department of Laboratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University)
Ryoji Noritake
President, Health and Global Policy Institute (HGPI)
Keizo Takemi (Member of the House of Councillors)
Building off of his long history of work in the global health field, including on AMR, Mr. Takemi spoke about the complex and pressing issue of AMR, including the importance of working to resolve issues related to the development and creation of new antimicrobials specifically to address AMR, through collaborations among the Cabinet Secretariat (including the Coordination Office of Measures on Emerging Infectious Diseases, and the Healthcare Policy Office), MHLW, the Ministry of Foreign Affairs (MOFA), the private sector, and academia.
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Survey Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Preliminary Version) (September 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
Featured Posts
-
2024-09-26
[Registration Open] HGPI Salon Special Edition “The 2024 U.S. Presidential Election’s Impact on Japan’s Healthcare Policies: Future Implications for U.S.-China Relations and U.S.-Japan Cooperation” (October 28, 2024)
-
2024-10-07
[Registration Open] International Dialogue “Fostering Community and Citizen-led Approaches to AMR: Lessons from Antibiotic Smart Sweden” (October 25, 2024)
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Open] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)
-
2024-10-10
[Event Report] HGPI Special Seminar Commemorating Dementia Month and World Alzheimer’s Month “Examining the Role of Industry in Creating a Dementia-Inclusive Society” (September 19, 2024)